3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonic Acid CAS 61260-15-9 Olaparib Intermediate Factory
High Purity, Commercial Production
Olaparib uye Inoenderana Nepakati:
Olaparib CAS 763113-22-0
2-Fluoro-5-Formylbenzonitrile CAS 218301-22-5
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid CAS 763114-26-7
1-(Cyclopropylcarbonyl)piperazine Hydrochloride CAS 1021298-67-8
3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonic Acid CAS 61260-15-9
| Chemical Name | 3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonic Acid |
| Mashoko anoreva zvakafanana | Dimethyl 3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonate |
| Nhamba yeCAS | 61260-15-9 |
| Nhamba yeCAT | RF-PI453 |
| Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
| Molecular Formula | C10H11O5P |
| Molecular Weight | 242.17 |
| Brand | Ruifu Chemical |
| Item | Zvinotsanangurwa |
| Chitarisiko | Upfu Huchena kana Hunenge Huchena |
| Kuchena | ≥98.0% |
| Kunyorova (KF) | ≤0.50% |
| Zvose Zvisina Kuchena | ≤2.0% |
| Test Standard | Enterprise Standard |
| Usage | Pakati peOlaparib (CAS: 763113-22-0) PARP-Inhibitor |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.
3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonic Acid (CAS: 61260-15-9), pakati peOlaparib (CAS: 763113-22-0).Olaparib imhando yenovel poly ADP-ribose polymerase (PARP) inhibitors, inosanganisira PARP1, PARP2, uye PARP3.PARP inopindirana neDNA-yekugadzirisa mashandiro anoita basa rakakosha mukugadzirisa kukuvara kweDNA uye apoptosis, saka olaparib inonangana neiyo DNA yekugadzirisa mashandiro eiyo inonangana sero DNA kugadzirisa uye inotora mhedzisiro nekurwisa kusasimba kwakanyanya kwekenza maseru anotakura shanduko muBRCA1 uye. BRCA2.Nekuda kwemuchina uyu, unogona kushandiswa kurapa kurapa kwevarwere vegomarara reovarian rakanyanya kudzokororwa ane chirwere chegomarara rezamu (BRCA) mutation pamwe nekuve nehanya nemushonga weplatinamu.
